Track Precipio, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Precipio, Inc. PRPO · Stock Open Precipio, Inc. in new tab

22.13 USD
EPS
-0.59
P/B
2.67
ROE
-8.00
Beta
1.44
Loading chart...
Key Metrics
Earnings dateNov. 16, 2026
EPS-0.59
Book Value8.29
Price to Book2.67
Debt/Equity24.84
% Insiders13.066%
Growth
Revenue Growth0.08%
Estimates
Forward P/E56.74
Forward EPS0.39

DCF valuation

Model fair value for Precipio, Inc. (PRPO)
Result
Sign in to run the valuation for PRPO.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Precipio, Inc. Logo Precipio, Inc. Analysis (PRPO)

United States Health Care Official Website Stock

Is Precipio, Inc. a good investment? Precipio, Inc. (PRPO) is currently trading at 22.13 USD.

Earnings Schedule: Precipio, Inc. is expected to release its next earnings report on Nov. 16, 2026. The market consensus estimate for Forward EPS is 0.39.

Investor FAQ

Does Precipio, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Precipio, Inc.?

Precipio, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Nov. 16, 2026. The company currently has a trailing EPS of -0.59.

Company Profile

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.

Exchange Ticker
NMS (United States) PRPO
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
April 29, 2019 0.07
Sept. 22, 2023 1:20
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion